Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
J
067290
vs
K
KOSPI 200
Over the past 12 months, JW Shinyak Corp has underperformed KOSPI 200, delivering a return of +111% compared to KOSPI 200's +112% growth.
Stocks Performance
067290 vs KOSPI 200
Performance Gap
067290 vs KOSPI 200
Performance By Year
067290 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
JW Shinyak Corp
Glance View
JW Shinyak is a South Korean pharmaceutical company that makes and sells medicines for hospitals and patients. Its product line includes prescription drugs and injectable treatments, along with sterile medical solutions such as IV fluids and other hospital-use formulations. The company’s main customers are hospitals, clinics, pharmacies, and drug distributors that buy these products for patient care. The company makes money by manufacturing these medicines and selling them through healthcare and distribution channels. In this business, demand comes less from consumer branding and more from medical use, so sales depend on doctor prescriptions, hospital purchasing, and the ability to meet strict quality and regulatory standards. What makes JW Shinyak’s role different is that it sits in the middle of the healthcare supply chain as a maker of essential, regulated products that must be produced reliably and in sterile conditions. That gives it a business model built around repeat institutional orders and long-term trust with medical buyers rather than one-time retail sales.